Schizophrenia is a treatable brain-based condition that affects how a person thinks, feels, and experiences the world. With early, coordinated specialty care, young people build meaningful, fulfilling lives, not just stable ones.
Schizophrenia is a heterogeneous neurodevelopmental syndrome characterized by profound disruptions in perception, cognition, and social functioning. It carries a staggering $366.8 billion annual societal cost in the U.S. To learn more about impaired executive function associated with schizophrenia, and the disability it causes, see our tutorial on the Dysexecutive Syndrome.
Direct vs. indirect societal costs (billions USD)
The "Two-Hit" Hypothesis suggests a genetic predisposition combined with environmental stressors triggers the onset.
Excessive synaptic pruning during late adolescence due to C4 gene variations leads to reduced dendritic density in the prefrontal cortex.
How psychosis develops →High-potency THC (>15%) desensitizes CB1 receptors, removing the “brake” on dopaminergic firing in the adolescent brain.
Cannabis-induced psychosis →Source: Multi-site European case-control study
Understanding the heterogeneity of the disorder requires distinguishing between these four distinct but overlapping areas of impairment.
Psychotic manifestations that represent a distortion or excess of normal experience. These hallmark features typically drive clinical presentation.
Hyperactivity in the mesolimbic dopamine pathway. Over-activation of D2 receptors leads to "aberrant salience", assigning significance to random stimuli.
A deeper look at the neurocognitive and social-cognitive impairments that drive long-term functional outcomes.
Learn more about the cognitive deficits of psychosis →Evidence-based cognitive remediation programs, restorative and compensatory approaches that build real-world functional gains.
Learn how we treat cognitive impairment →An interactive guide to antipsychotic pharmacology, three generations of agents, clozapine's unique advantage, and the novel muscarinic target.
Learn more about the pharmacotherapy of schizophrenia →Clozapine remains the only antipsychotic proven effective in treatment-resistant schizophrenia, where two prior trials have failed. It also uniquely reduces suicidality, but requires regular blood monitoring for neutropenia, which is why it remains under-prescribed despite its superior efficacy.
Treatment has evolved from simple symptom suppression to a holistic focus on cognitive remediation and functional independence.
Aerobic exercise (150 mins/week) acts as a physiological "primer." It triggers BDNF release, which creates a window of neuroplasticity.
Software-based training to target working memory and processing speed.
Explicit learning to recognize facial emotions and the intentions of others.
Early symptoms are often subtle. Recognizing them shortens the duration of untreated psychosis (DUP), the single most modifiable predictor of long-term outcome.
The RAISE-ETP trial, funded by NIMH and published in the American Journal of Psychiatry, established CSC as the standard of care for early schizophrenia. Compared with treatment-as-usual, CSC produces better symptom control, more time in school and work, higher quality of life, and longer treatment engagement. The benefit is largest when DUP is short, which is why we move quickly.
Pand Health strictly adheres to Coordinated Specialty Care (CSC), the evidence-based standard of care for psychosis-spectrum conditions established by the NIMH RAISE initiative and operationalized in the NAVIGATE model. CSC is a team-based, recovery-oriented approach that integrates psychiatry and medication management, individual resilience-focused therapy, family education and support, supported employment and education, and case management into a single coordinated plan. Decades of research, including the landmark RAISE-ETP trial, show that CSC produces measurably better outcomes than treatment-as-usual: more time in school and work, stronger relationships, fewer hospitalizations, and a faster path to functional recovery.
Our clinical team is here to listen. A member will reach out within one business day.
Schizophrenia rarely arrives alone. Anxiety, OCD, depression, substance use, trauma, and autistic traits frequently travel alongside it, and when they do, generic mental health programs lose the thread. Pand Health was built to keep the whole picture in view: we treat the psychotic process and every co-occurring layer in one coordinated plan, with the same team, at the same time. That is how functional recovery becomes the expectation rather than the exception.
A clinical team member will reach out within one business day.
This page was medically reviewed by Eric Wexler M.D., Ph.D. on August 14, 2026.
